These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1353 related articles for article (PubMed ID: 16921036)
1. Analysis of prognostic factors in patients with nonmetastatic rhabdomyosarcoma treated on intergroup rhabdomyosarcoma studies III and IV: the Children's Oncology Group. Meza JL; Anderson J; Pappo AS; Meyer WH; J Clin Oncol; 2006 Aug; 24(24):3844-51. PubMed ID: 16921036 [TBL] [Abstract][Full Text] [Related]
2. Comparison of results of a pilot study of alternating vincristine/doxorubicin/cyclophosphamide and etoposide/ifosfamide with IRS-IV in intermediate risk rhabdomyosarcoma: a report from the Children's Oncology Group. Arndt CA; Hawkins DS; Meyer WH; Sencer SF; Neglia JP; Anderson JR Pediatr Blood Cancer; 2008 Jan; 50(1):33-6. PubMed ID: 17091486 [TBL] [Abstract][Full Text] [Related]
3. Prognostic factors and surgical treatment guidelines for children with rhabdomyosarcoma of the perineum or anus: a report of Intergroup Rhabdomyosarcoma Studies I through IV, 1972 through 1997. Blakely ML; Andrassy RJ; Raney RB; Anderson JR; Wiener ES; Rodeberg DA; Paidas CN; Lobe TE; Crist WM; J Pediatr Surg; 2003 Mar; 38(3):347-53. PubMed ID: 12632347 [TBL] [Abstract][Full Text] [Related]
4. Pretreatment TNM staging of childhood rhabdomyosarcoma: a report of the Intergroup Rhabdomyosarcoma Study Group. Children's Cancer Study Group. Pediatric Oncology Group. Lawrence W; Anderson JR; Gehan EA; Maurer H Cancer; 1997 Sep; 80(6):1165-70. PubMed ID: 9305719 [TBL] [Abstract][Full Text] [Related]
5. Soft tissue sarcoma or malignant mesenchymal tumors in the first year of life: experience of the International Society of Pediatric Oncology (SIOP) Malignant Mesenchymal Tumor Committee. Orbach D; Rey A; Oberlin O; Sanchez de Toledo J; Terrier-Lacombe MJ; van Unnik A; Quintana E; Stevens MC J Clin Oncol; 2005 Jul; 23(19):4363-71. PubMed ID: 15994146 [TBL] [Abstract][Full Text] [Related]
6. Assessment of response to induction therapy and its influence on 5-year failure-free survival in group III rhabdomyosarcoma: the Intergroup Rhabdomyosarcoma Study-IV experience--a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group. Burke M; Anderson JR; Kao SC; Rodeberg D; Qualman SJ; Wolden SL; Meyer WH; Breitfeld PP; J Clin Oncol; 2007 Nov; 25(31):4909-13. PubMed ID: 17971587 [TBL] [Abstract][Full Text] [Related]
7. Long-term results of three-dimensional conformal radiation therapy for patients with rhabdomyosarcoma. Wolden SL; La TH; LaQuaglia MP; Meyers PA; Kraus DH; Wexler LH Cancer; 2003 Jan; 97(1):179-85. PubMed ID: 12491519 [TBL] [Abstract][Full Text] [Related]
8. Treatment of nonmetastatic rhabdomyosarcoma in childhood and adolescence: third study of the International Society of Paediatric Oncology--SIOP Malignant Mesenchymal Tumor 89. Stevens MC; Rey A; Bouvet N; Ellershaw C; Flamant F; Habrand JL; Marsden HB; Martelli H; Sanchez de Toledo J; Spicer RD; Spooner D; Terrier-Lacombe MJ; van Unnik A; Oberlin O J Clin Oncol; 2005 Apr; 23(12):2618-28. PubMed ID: 15728225 [TBL] [Abstract][Full Text] [Related]
9. Results of the Intergroup Rhabdomyosarcoma Study Group D9602 protocol, using vincristine and dactinomycin with or without cyclophosphamide and radiation therapy, for newly diagnosed patients with low-risk embryonal rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group. Raney RB; Walterhouse DO; Meza JL; Andrassy RJ; Breneman JC; Crist WM; Maurer HM; Meyer WH; Parham DM; Anderson JR J Clin Oncol; 2011 Apr; 29(10):1312-8. PubMed ID: 21357783 [TBL] [Abstract][Full Text] [Related]
10. Benefit of intensified therapy for patients with local or regional embryonal rhabdomyosarcoma: results from the Intergroup Rhabdomyosarcoma Study IV. Baker KS; Anderson JR; Link MP; Grier HE; Qualman SJ; Maurer HM; Breneman JC; Wiener ES; Crist WM J Clin Oncol; 2000 Jun; 18(12):2427-34. PubMed ID: 10856103 [TBL] [Abstract][Full Text] [Related]
11. Cooperative trial CWS-91 for localized soft tissue sarcoma in children, adolescents, and young adults. Dantonello TM; Int-Veen C; Harms D; Leuschner I; Schmidt BF; Herbst M; Juergens H; Scheel-Walter HG; Bielack SS; Klingebiel T; Dickerhoff R; Kirsch S; Brecht I; Schmelzle R; Greulich M; Gadner H; Greiner J; Marky I; Treuner J; Koscielniak E J Clin Oncol; 2009 Mar; 27(9):1446-55. PubMed ID: 19224858 [TBL] [Abstract][Full Text] [Related]
12. What constitutes optimal therapy for patients with rhabdomyosarcoma of the female genital tract? Arndt CA; Donaldson SS; Anderson JR; Andrassy RJ; Laurie F; Link MP; Raney RB; Maurer HM; Crist WM Cancer; 2001 Jun; 91(12):2454-68. PubMed ID: 11413538 [TBL] [Abstract][Full Text] [Related]
13. Which patients with microscopic disease and rhabdomyosarcoma experience relapse after therapy? A report from the soft tissue sarcoma committee of the children's oncology group. Smith LM; Anderson JR; Qualman SJ; Crist WM; Paidas CN; Teot LA; Pappo AS; Link MP; Grier HE; Wiener ES; Breneman JC; Raney RB; Maurer HM; Donaldson SS J Clin Oncol; 2001 Oct; 19(20):4058-64. PubMed ID: 11600608 [TBL] [Abstract][Full Text] [Related]
14. Intergroup rhabdomyosarcoma study-IV: results for patients with nonmetastatic disease. Crist WM; Anderson JR; Meza JL; Fryer C; Raney RB; Ruymann FB; Breneman J; Qualman SJ; Wiener E; Wharam M; Lobe T; Webber B; Maurer HM; Donaldson SS J Clin Oncol; 2001 Jun; 19(12):3091-102. PubMed ID: 11408506 [TBL] [Abstract][Full Text] [Related]
15. European intergroup studies (MMT4-89 and MMT4-91) on childhood metastatic rhabdomyosarcoma: final results and analysis of prognostic factors. Carli M; Colombatti R; Oberlin O; Bisogno G; Treuner J; Koscielniak E; Tridello G; Garaventa A; Pinkerton R; Stevens M J Clin Oncol; 2004 Dec; 22(23):4787-94. PubMed ID: 15570080 [TBL] [Abstract][Full Text] [Related]
16. Efficacy of topotecan and cyclophosphamide given in a phase II window trial in children with newly diagnosed metastatic rhabdomyosarcoma: a Children's Oncology Group study. Walterhouse DO; Lyden ER; Breitfeld PP; Qualman SJ; Wharam MD; Meyer WH J Clin Oncol; 2004 Apr; 22(8):1398-403. PubMed ID: 15007087 [TBL] [Abstract][Full Text] [Related]
17. Role of surgery for nonmetastatic abdominal rhabdomyosarcomas: a report from the Italian and German Soft Tissue Cooperative Groups Studies. Cecchetto G; Bisogno G; Treuner J; Ferrari A; Mattke A; Casanova M; Dall'Igna P; Zanetti I; Volpato S; Siracusa F; Scarzello G; Boglino C; Carli M; Cancer; 2003 Apr; 97(8):1974-80. PubMed ID: 12673726 [TBL] [Abstract][Full Text] [Related]
18. Characteristics and outcomes of rhabdomyosarcoma patients with isolated lung metastases from IRS-IV. Rodeberg D; Arndt C; Breneman J; Lyden E; Donaldson S; Paidas C; Andrassy R; Meyer W; Wiener E J Pediatr Surg; 2005 Jan; 40(1):256-62. PubMed ID: 15868594 [TBL] [Abstract][Full Text] [Related]
19. Rhabdomyosarcoma and undifferentiated sarcoma in the first two decades of life: a selective review of intergroup rhabdomyosarcoma study group experience and rationale for Intergroup Rhabdomyosarcoma Study V. Raney RB; Anderson JR; Barr FG; Donaldson SS; Pappo AS; Qualman SJ; Wiener ES; Maurer HM; Crist WM J Pediatr Hematol Oncol; 2001 May; 23(4):215-20. PubMed ID: 11846299 [TBL] [Abstract][Full Text] [Related]